KIAA1755: A Potential Drug Target for Various Diseases (G85449)

Target Name: KIAA1755

NCBI ID: G85449

KIAA1755

KIAA1755: A Potential Drug Target for Various Diseases

KIAA1755 is a protein that is expressed in most tissues of the body and is involved in various cellular processes such as cell adhesion, migration, and invasion. It is a member of the integrin receptor family, which is a large family of transmembrane proteins that play a crucial role in cell-cell interactions and tissue organization.

Recent studies have identified KIAA1755 as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these diseases has been attributed to its involvement in the regulation of cellular processes that are disrupted in these conditions.

One of the key mechanisms by which KIAA1755 is involved in disease is its role in the regulation of cell-cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. In cancer, this process can be disrupted, leading to the development of cancer cells. KIAA1755 has been shown to play a role in regulating cell-cell adhesion by controlling the activity of integrins, which are proteins that help cells stick together.

In addition to its role in cell-cell adhesion, KIAA1755 has also been shown to be involved in the regulation of cell migration. Migration is the process by which cells move from one location to another in the body. In cancer, this process can be disrupted, leading to the development of cancer cells. KIAA1755 has been shown to play a role in regulating cell migration by controlling the activity of motors, which are proteins that help cells move.

KIAA1755 has also been shown to be involved in the regulation of inflammation. Inflammation is a natural response of the immune system to injury or infection. However, chronic inflammation can lead to a range of diseases, including cancer and neurodegenerative diseases. KIAA1755 has also been shown to play a role in regulating inflammation by controlling the activity of immune cells and promoting the production of anti-inflammatory cytokines.

In conclusion, KIAA1755 is a protein that is involved in various cellular processes that are disrupted in a wide range of diseases. Its role in these processes makes it a potential drug target for cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of KIAA1755 in these diseases and to develop effective treatments.

Protein Name: KIAA1755

The "KIAA1755 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIAA1755 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets